Literature DB >> 28750799

Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Khalil Eldeeb1, Sandra Leone-Kabler2, Allyn C Howlett3.   

Abstract

G protein-coupled receptors (GPCRs) are important regulators of cellular signaling functions and therefore are a major target for drug discovery. The CB1 cannabinoid receptor is among the most highly expressed GPCRs in neurons, where it regulates many differentiated neuronal functions. One model system for studying the biochemistry of neuronal responses is the use of neuroblastoma cells originating from the C1300 tumor in the A/J mouse, including cloned cell lines NS20, N2A, N18TG2, N4TG1, and N1E-115, and various immortalized hybrids of neurons with N18TG2 cells. GPCR signal transduction is mediated through interaction with multiple types and subtypes of G proteins that transduce the receptor stimulus to effectors. The [35S]GTPɣS assay provides a valuable pharmacological method to evaluate efficacy and potency in the first step in GPCR signaling. Here, we present detailed protocols for the [35S]GTPɣS-binding assay to measure the total G protein binding and the antibody-targeted scintillation proximity assay to measure specific Gα proteins in neuroblastoma cell membrane preparations. This chapter presents step-by-step methods from cell culture, membrane preparation, assay procedures, and data analysis.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CP55940; Cannabinoid receptor; G protein; GTPɣS; N18TG2; Neuroblastoma

Mesh:

Substances:

Year:  2017        PMID: 28750799      PMCID: PMC6535336          DOI: 10.1016/bs.mie.2017.06.028

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  71 in total

1.  The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.

Authors:  S Mukhopadhyay; H H McIntosh; D B Houston; A C Howlett
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

Review 2.  Principles: extending the utility of [35S]GTP gamma S binding assays.

Authors:  Graeme Milligan
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

3.  Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue.

Authors:  S I Said; R N Rosenberg
Journal:  Science       Date:  1976-05-28       Impact factor: 47.728

4.  Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay.

Authors:  N W DeLapp; J H McKinzie; B D Sawyer; A Vandergriff; J Falcone; D McClure; C C Felder
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

Review 5.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

6.  Identifying genes involved in regulating differentiation of neuroblastoma cells.

Authors:  A Rudie Hovland; P Nahreini; C P Andreatta; J Edwards-Prasad; K N Prasad
Journal:  J Neurosci Res       Date:  2001-05-01       Impact factor: 4.164

7.  Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception.

Authors:  R A Ross; A A Coutts; S M McFarlane; S Anavi-Goffer; A J Irving; R G Pertwee; D J MacEwan; R H Scott
Journal:  Neuropharmacology       Date:  2001       Impact factor: 5.250

8.  Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors.

Authors:  Isao Ishii; Jerold Chun
Journal:  Neuroreport       Date:  2002-04-16       Impact factor: 1.837

9.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.

Authors:  N R Cashman; H D Durham; J K Blusztajn; K Oda; T Tabira; I T Shaw; S Dahrouge; J P Antel
Journal:  Dev Dyn       Date:  1992-07       Impact factor: 3.780

View more
  4 in total

1.  CB1 cannabinoid receptor-phosphorylated fourth intracellular loop structure-function relationships.

Authors:  Khalil Eldeeb; Anjali D Ganjiwale; Indu R Chandrashekaran; Lea W Padgett; Jason Burgess; Allyn C Howlett; Sudha M Cowsik
Journal:  Pept Sci (Hoboken)       Date:  2018-12-14

Review 2.  Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.

Authors:  Emily E Oliver; Erin K Hughes; Meaghan K Puckett; Rong Chen; W Todd Lowther; Allyn C Howlett
Journal:  Biomolecules       Date:  2020-11-27

3.  WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells.

Authors:  Victor M Pulgar; Allyn C Howlett; Khalil Eldeeb
Journal:  Cells       Date:  2022-09-21       Impact factor: 7.666

Review 4.  CB1 Cannabinoid Receptor Signaling and Biased Signaling.

Authors:  Luciana M Leo; Mary E Abood
Journal:  Molecules       Date:  2021-09-06       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.